While the test doesn't directly predict constipation, it reveals your metabolic sensitivity profile, helping your provider anticipate side effects and customize your dose escalation to minimize them
The described case indicates that educating patients on the procedure in the event of vomiting, with control of ketonemia, is a targeted action to reduce the risk of euDKA
3C, the mRNA levels of serine biosynthesis enzymes (PHGDH, PSAT1, PSPH and SLC1A4) was positively correlated with TP63 mRNA levels
This suggests some durability of effect even after discontinuation, though the protective benefit was stronger during active treatment
The mean levels of monitoring variables before and after intervention are shown in Table 4
We recommend a consultation with one of our licensed practitioners to confirm suitability